Skip to content

Collect Digital Data

Opportunity

Participants expect a simple and convenient experience participating on clinical trials. To accomplish this goal, sponsors should consider the type, design and delivery of device (e.g., personal device,  provided by study, etc.) for participants to achieve accessibility, flexibility, convenience and maintain privacy. 

Considerations to Help Action the Opportunity

  • Understand if the clinical trial design supports the applications of digital patient solutions
  • Understand the needs and preferences of the participants taking part in the trial
    • Does the population have access to devices and data plans, or would they need these to be provisioned?
    • What devices would participants already have that could be used for clinical trials (e.g., wearables / sensors, glucometers, weighing scales, phones / tablets, etc.​)?
    • Understand impact on health equity (i.e., geographic, socioeconomic barriers) when implementing digital solutions 
  • Partner with sites to gain their input on the impact of multiple services, training, and technology implementation
  • Understand how the device may impact data integrity, regulatory landscape, site implementation and overall costs  
  • Define how technology is designed, communicated and delivered for / to participants
  • Define backup options (e.g., when a participant is unable to connect to device)

Value and Potential Benefits

  • Increases access and ease of participation for participants on clinical trials by potentially reducing the number of site visits
  • Allows for more robust datasets with improved data compliance and quality by enabling direct entry and near real-time review of data

Related Blog Posts

Solving the Clinical Trial Data Problem

In a new LinkedIn article, Janice Chang, CEO of TransCelerate, and Nicholas Brooke, CEO of The Synergist & PFMD, outline how efforts like the Clinical Trial Data Network, supported by TransCelerate through technical expertise and industry-vetted solutions from our Digital Data Flow initiative, aim to make clinical trial information more structured, connected, and accessible across…

The Clinical Trial Enterprise: Can AI Fix It?

Artificial Intelligence (AI) is reasonably well established in discovery and preclinical research, with success in areas such as target identification and molecular modeling. However, in clinical development, adoption has been fragmented and challenging to embed across the lifecycle.  Read the full article by Rob DiCicco from Drug Discovery News here.

Redesigning Clinical Trials Using Artificial Intelligence

While tech evangelists often tout artificial intelligence (AI) as healthcare’s silver bullet, the reality in clinical trials is more complex. Adoption has been cautious, shaped as much by concerns around trust and governance as by technical hurdles. Still, beneath the surface, methodical innovation is gaining momentum. AI is beginning to reshape how trials are designed,…